RxDoctor Payments Data

John Roberts, MD

Family Medicine · Danville, CANPI 1700856978

Payments from drug & device makers

$17,651in general payments, 2019–2025

Across 995 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • Amgen$1K
  • GSK$904
  • AstraZeneca$829
  • Johnson & Johnson$669
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$17,55199%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)174$2,280
Pfizer71$1,216
Amgen(2 entities)53$1,120
GSK55$904
AstraZeneca45$829
Johnson & Johnson41$669
Esperion Therapeutics, Inc.33$659
Boehringer Ingelheim34$629
Otsuka America Pharmaceutical, Inc.27$552
Novo Nordisk30$535
Bausch Health US, LLC26$456
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$429
Teva Pharmaceuticals USA, Inc.16$401
Almatica Pharma LLC23$380
Bayer17$378
Merck20$371
Lilly USA, LLC21$342
Ironshore Pharmaceuticals Inc.15$304
Astellas Pharma US Inc12$284
Novartis15$260
Lundbeck LLC12$256
Antares Pharma, Inc.15$251
Biohaven Pharmaceuticals, Inc.8$214
Takeda Pharmaceuticals U.S.A., Inc.24$213
Sanofi-aventis U.S. LLC13$208
Adlon Therapeutics L.p.10$204
IBSA Pharma Inc.8$188
E.r. Squibb & Sons, L.L.C.4$170
Eisai Inc.10$163
Sumitomo Pharma America, Inc.7$155
Biohaven Pharmaceutical Holding Company Ltd.6$151
Sanofi Pasteur Inc.7$140
Neurocrine Biosciences, Inc.6$133
Arbor Pharmaceuticals, Inc.8$122
Exact Sciences5$109
Axsome Therapeutics, Inc.4$107
Alfasigma USA, Inc.5$96
Endo Pharmaceuticals Inc.6$96
Corium, LLC4$95
Therapeuticsmd, Inc.6$85
Regeneron Healthcare Solutions, Inc.5$85
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$84
Abbott3$70
Boston Scientific2$63
Nestle Healthcare Nutrition Inc.3$62
Agios Pharmaceuticals, Inc.2$59
Currax Pharmaceuticals LLC4$57
Daiichi Sankyo Inc.3$50
Acadia Pharmaceuticals Inc2$50
Alkermes, Inc.2$48
Scilex Pharmaceuticals Inc.3$47
Verity Pharmaceuticals Inc.2$47
Kowa Pharmaceuticals America, Inc.2$46
Azurity Pharmaceuticals, Inc.2$45
EUSA Pharma (US) LLC2$43
Shire North American Group Inc2$42
Phathom Pharmaceuticals, Inc.2$39
VBI Vaccine (delaware) Inc.2$34
Genentech USA, Inc.2$34
Amarin Pharma, Inc.2$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,651 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$426,497
Medicare patients
1,149
Services billed
12,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban61$70,989
JardianceEmpagliflozin47$49,986
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$41,952
XareltoRivaroxaban42$41,579
MounjaroTirzepatide39$34,996
Synjardy XrEmpagliflozin/Metformin Hcl24$29,480
Repatha SureclickEvolocumab30$28,642
OzempicSemaglutide24$28,190
JanuviaSitagliptin Phosphate14$17,032
SynjardyEmpagliflozin/Metformin Hcl17$15,717
MyrbetriqMirabegron14$13,059
TrulicityDulaglutide12$12,467
NexletolBempedoic Acid13$12,411
SynthroidLevothyroxine Sodium72$7,702
Janumet XrSitagliptin Phos/Metformin Hcl11$7,525

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Synjardy$629$95,18488 claims
PfizerEliquis$1,216$70,98961 claims
GSKTrelegy Ellipta, Breo Ellipta$904$49,35563 claims
Lilly USA, LLCMounjaro, Trulicity$342$47,46251 claims
Johnson & JohnsonXarelto$669$41,57942 claims
Novo NordiskOzempic$535$28,19024 claims
MerckJanuvia, Janumet Xr$371$24,55725 claims
Astellas Pharma US IncMyrbetriq$284$13,05914 claims
Esperion Therapeutics, Inc.Nexletol$659$12,41113 claims
AbbVieSynthroid$2,280$7,70272 claims
Sumitomo Pharma America, Inc.Gemtesa$155$7,20915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.

Other family medicine in Danville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →